Latest Ascites Stories
ZUG, Switzerland, February 11 /PRNewswire/ -- NovaShunt today announced the initiation of its pivotal multi- center clinical study named PIONEER, a Prospective, multi-center, open label, non-randomized study to Investigate the safety and perfOrmance of the Automated Fluid ShuNt in patiEnts with ascitEs and diuretic Resistance. The study is designed to evaluate the safety and performance of the Automated Fluid Shunt (AFS) System in replacing the need for paracentesis, the standard...
CLAREMONT, Calif., Jan. 15 /PRNewswire/ -- Anti-Cancer Institute (ACI) introduces PANLIAN Concentrate, a medicinal herbal supplement proven to aid in combating tumors. PANLIAN, a natural herb, is primarily grown in China's Guizhou high plateau at 3,000 meters above sea level.
A research article to be published on August 7 , 2009 in the World Journal of Gastroenterology addresses this question. Study designed by Dr. El-Bokl and performed by Dr. Senousy and colleagues evaluated using spot urine Na/K ratio as an alternative. Forty patients with liver cirrhosis and ascites were admitted to Ain Shams University Hospital in Cairo, Egypt.
Arginine vasopressin (AVP) receptor antagonist now available in new premixed formulation DEERFIELD, Ill., April 1 /PRNewswire/ -- Astellas Pharma US, Inc.
CHICAGO, Oct. 27 /PRNewswire/ -- ReachMD XM 157 announces a new "Medical Industry Feature of the Week" highlighting a vasopressin receptor antagonist and its effects on management of euvolemic and hypervolemic hyponatremia in the hospital setting.
DEERFIELD, Ill., Oct. 22 /PRNewswire/ -- Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new premixed formulation of Vaprisol: Vaprisol(R) (conivaptan hydrochloride injection) Premixed in 5% Dextrose.
DEAR DR. DONOHUE: I am writing this for my husband. About five years ago, he was diagnosed with hemochromatosis. The iron damaged his liver and pancreas. He is not a candidate for a liver transplant.
Movetis has announced that M0002 is progressing to Phase IIb following positive results of a Phase IIa multiple-dosing trial for the treatment of ascites.
- Withering but not falling off, as a blossom that persists on a twig after flowering.